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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S3383) weeks post-surgery; or from 4 weeks post-surgery until sacriﬁce at 8
weeks (group 2) (n ¼ 8/antibody/group). At sacriﬁce knees were ﬁxed,
bone changes analysed by mCT, joints then decalciﬁed and OA pathology
scored (average of 2 blinded observers) on serial sagittal sections. SOST
and DKK1 were immunolocalized in 3 mice of each group/antibody.
Results: Treatments were well tolerated with no adverse reactions
observed; all animals completed the study. The signiﬁcant effects of
anti-SOST compared with IgG in operated limbs from the 3 groups are
summarized in Table 1. Increased tibial cortical bone thickness and
subchondral trabecular bone volume were seen by mCT in all groups
with anti-SOST compared with IgG (p<0.05), conﬁrming the efﬁcacy of
the SOST inhibition. However, subchondral bone plate thickness was
only increased by anti-SOST in groups 1 and 2 (p<0.05). Similarly,
histological scoring of subchondral bone sclerosis was only signiﬁcantly
increased with short-term SOST inhibition (groups 1 and 2). Inhibition
of SOST only later in ptOA development (group 2) led to increased
osteophyte size (p<0.05). Importantly, this later anti-SOST treatment
(group 2) also increased articular cartilage structural damage (p<0.05).
Immunohistochemistry revealed that anti-SOST antibody increased the
number of SOST positive cells in calciﬁed cartilage (x24-86%) and sub-
chondral bone (x33-124%) in all groups. While short term SOST inhib-
ition (groups 1 and 2) also increased DKK1 positive cells throughout the
cartilage (x47-180%) and subchondral bone (x250-260%), long-term
SOST blockade (group 3) reduced DKK1 positive cells in all tissues (to
30-60%).
Conclusion: Blocking SOST by systemic administration of a monoclonal
antibody had detrimental effects on the progression of DMM-induced
ptOA in mice. Importantly the effect was dependent on timing, being
more pronounced with short-term administration and particularly
when given later in disease. It is unclear whether the increase in car-
tilage damage (group 2), was a direct effect of anti-SOST on chon-
drocytes, inhibition of synovial SOST, or indirectly through changing
subchondral bone. That long-term SOST-blockade did not alter joint
pathology to the same extent as short-term treatment may be related to
different compensatory changes in other Wnt-regulatory proteins as
seen with DKK1. The temporal difference in SOST blockade in joint
versus distant skeleton may reﬂect when SOST expression in OA is most
pronounced and/or when increases in subchondral bone plate are most
rapid or important in disease progression. The latter may also explain
differences in our ﬁndings compared with those reported in rat ptOA,
where more pronounced and prolonged bone loss occurs. Improved
understanding of the regulation of Wnt signaling in different skeletal
and joint tissues with time, may lead to novel therapeutic approaches in
OA.Table 1
Parameters signiﬁcantly increased in anti-SOST compared to IgG treated mice (+ ¼ p < 0.05, - ¼ no change).
Micro CT Histology score
Cortical Bone Subchondral Trabecular Bone Subchondral Bone Plate Subchondral Bone Plate Osteophyte Size Articular cartilage Erosion
Group 11-4 weeks + + + + - -
Group 24-8 weeks + + + + + +
Group 31-8 weeks + + - - - -591
IDENTIFICATION OF GREMLIN1 AS A CATABOLIC FACTOR INDUCED
BY MECHANICAL STRESS LOADING IN ARTICULAR CHONDROCYTES
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Purpose: Excessive mechanical stress loading on articular cartilage is
one of the major factors of osteoarthritis (OA); however, the molecular
mechanisms of cartilage degradation by such loading remain unclear.
The present study therefore analyzed gene expression proﬁles of
articular chondrocytes under mechanical stress loading and inves-
tigated functions of the candidate gene.
Methods: To load mechanical stress on cultured chondrocytes, we used
a programmable cell stretcher system, STB-140 (STREX). Primary
articular chondrocytes from 5-day-old mouse knee joints were seeded
onto stretch chambers at a concentration of 1.0106 cells/chamber.
After 48 h of culture on the chambers, we initially applied a uni-axial
cyclic cell stretch (0.5 Hz, 10% stretch) to the articular chondrocytes for
30 min, then cultured them for an additional 24 h. cDNA microarray(SurePrint G3, Agilent Expression Array) analyses were performed using
samples before and after the mechanical loading. The gene expressions
were conﬁrmed by real-time RT-PCR and immunohistochemistry. The
catabolic ability was assessed by measuring the concentration of
aggrecan released from cultured 3-week-old mouse femoral heads
using the dimethylmethylene blue dye-binding assay. We used mouse
primary articular chondrocytes and mouse chondrogenic cell line
ATDC5 for further in vitro functional analyses.
Results: Microarray analyses revealed that 2,076 genes were increased
more than twice by the mechanical stress loading. Among them, we
focused on Gremlin1, which is one of the most highly expressed genes.
Gremlin1 is known to be a secreted protein that regulates limb devel-
opment as a BMP antagonist during skeletal development, although its
function in articular cartilage is unknown. Immunohistochemistry
revealed that Gremlin1 protein was localized in cytoplasm of mouse
normal knee articular chondrocytes, and the expression was enhanced
in the cells of the experimental mouse OAmodel. In the organ culture of
mouse femoral heads, recombinant human (rh) Gremlin1 treatment
increased aggrecan release into the medium in a dose-dependent
manner. In primary culture of mouse articular chondrocytes, rhGrem-
lin1 treatment induced the expressions of catabolic factors including
Mmp13 and Adamts5, and suppressed those of anabolic factors
including Col2a1, aggrecan and Sox9. Lentiviral overexpression of
Gremlin1 in ATDC5 cells also induced the catabolic factor expressions
and suppressed the anabolic factor expressions. In organ culture of
mouse femoral heads, rhBMP-7 treatment decreased the aggrecan
release, and this anti-catabolic effect was abolished by the co-treatment
of rhGremlin1. To further identify other signals related to the catabolic
effect of Gremlin1 under the mechanical stress, we performed pathway
analyses and gene ontology analyses using the microarray data and
Genespring software, and found the NF-kB signal to be the most potent
candidate pathway associated with both mechanical stress loading and
Gremlin1. To know the involvement of the NF-kB signal with the
catabolic effect by Gremlin1, we used conditional knockoutmice of Rela,
a representative transcription factor of the NF-kB signal. In the organ
culture of femoral heads from Col2a1-Cre;Relaﬂ/ﬂmice, rhGremlin1 did
not induce the aggrecan release, while it normally induced the release
in the control Relaﬂ/ﬂ femoral heads. We further conﬁrmed that sup-
pression of the NF-kB signal by an IKK inhibitor (BMS-345541) treat-
ment also diminished the increase of aggrecan release. Induction of
catabolic factors and suppression of anabolic fators by rhGremlin1 were
also diminished by the IKK inhibitor treatment.
Conclusion: We have identiﬁed Gremlin1 as a catabolic factor induced
by the mechanical stress loaded to articular chondrocytes, not onlythrough the BMP signal but also through the NF-kB signal. Gremlin1
may provide a novel therapeutic target of OA.
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A ROLE FOR TGFb-RII/MCP-5 AXIS DURING POST TRAUMATIC
OSTEOARTHRITIS AND POTENTIAL ROLE OF PTHRP IN MEDIATING
MCP-5 EFFECT
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Purpose: In previous studies we found that the down-regulation of the
chemokine MCP5 by TGF-b Type II receptor (TbRII) signaling is required
for joint development. MCP-5 role in arthritis is demonstrated by
human and animal studies. MCP-5, its human homologous MCP-1 and
their sole common receptor CCR2, are increased in the inﬂamed joints
